Leadership Team

PRESIDENT & CHIEF EXECUTIVE OFFICER

Jarlath serves as President & Chief Executive Officer of ABL and as a member of the Board of Directors. Jarlath was appointed CEO in October 2018 having previously served as Chief Commercial Officer when he joined ABL in August 2018…

CHIEF FINANCIAL OFFICER

A financial leader with exceptional analytical, communication, and interpersonal skills. Progressive background includes over twenty years of business experience with exposure to many functional areas in…

SENIOR VICE PRESIDENT, OPERATIONS

Experienced professional with more than 20 years of experience in facility design, start-up, and validation, clinical and commercial manufacturing, and process development. Experienced in technology transfer from…

VICE PRESIDENT, INNOVATION AND TRANSLATION

The Innovation and Translation team manages ABL’s portfolio of government contracts that drive the transformation of ideas to novel clinical products that prevent and treat infectious disease. The services the Innovation team provides include early discovery of suitable…

VICE PRESIDENT, IMMUNOLOGY

Dr. Lemiale has over 25 years of experience in immunology, applied to vaccine research and development. His scientific focus has been on preclinical development of vaccine candidates and on the development and…

VP OF BUSINESS DEVELOPMENT AND MARKETING

VP, Business Development and Marketing with over 15 years’ experience in the industry. Jennifer started her career at Avid Bioservices, Inc. as an analytical chemist where she supported…

DIRECTEUR GÉNÉRAL, ABL EUROPE

Dr. Mahieux joined ABL in January 2016 as ABL Europe General Manager. He has a strong experience in vaccine GMP manufacturing. He began his professional career with Pasteur Mérieux in 1993 and held…